Catalyzed process of making C5-substituted heterocyclic inhibitors of 11beta-hydroxy steroid dehydrogenase type 1

Details for Australian Patent Application No. 2006317070 (hide)

Owner Amgen, Inc.

Inventors Bunel, Emilio; Guram, Anil; Liu, Qingyian

Agent Knightsbridge Patent Attorneys

Pub. Number AU-B-2006317070

PCT Pub. Number WO2007/061600

Priority 60/738,574 22.11.05 US

Filing date 1 November 2006

Wipo publication date 31 May 2007

Acceptance publication date 23 June 2011

International Classifications

C07D 277/54 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/061600 Priority application(s): WO2007/061600

23 June 2011 Application Accepted

  Published as AU-B-2006317070

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006317072-Highly selective molecular confinement for the prevention and removal of taint in foods and beverages

2006317060-Composition for use in edible biodegradable articles and method of use